Genflow Biosciences Balance Sheet Health
Financial Health criteria checks 6/6
Genflow Biosciences has a total shareholder equity of £725.9K and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £1.1M and £345.7K respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
Interest coverage ratio | n/a |
Cash | UK£683.97k |
Equity | UK£725.92k |
Total liabilities | UK£345.74k |
Total assets | UK£1.07m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GENF's short term assets (£1.1M) exceed its short term liabilities (£345.7K).
Long Term Liabilities: GENF has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: GENF is debt free.
Reducing Debt: GENF has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GENF has sufficient cash runway for 5 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: GENF is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.